RecruitingPhase 1Biological interventionAdoptive Cell Therapy Long-term Follow-up (LTFU) StudyThis trial will evaluate long term safety of participants who have received AdaptImmune (ADP) adoptive cell therapy for up to 15 years following last adoptive cell therapy infusion.